Cargando…
Validation of the new graded prognostic assessment scale for brain metastases: a multicenter prospective study
BACKGROUND: Prognostic indexes are useful to guide tailored treatment strategies for cancer patients with brain metastasis (BM). We evaluated the new Graded Prognostic Assessment (GPA) scale in a prospective validation study to compare it with two published prognostic indexes. METHODS: A total of 28...
Autores principales: | Villà, Salvador, Weber, Damien C, Moretones, Cristina, Mañes, Anabel, Combescure, Christophe, Jové, Josep, Puyalto, Paloma, Cuadras, Patricia, Bruna, Jordi, Verger, Eugènia, Balañà, Carme, Graus, Francesc |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058011/ https://www.ncbi.nlm.nih.gov/pubmed/21366924 http://dx.doi.org/10.1186/1748-717X-6-23 |
Ejemplares similares
-
Radiation and concomitant chemotherapy for patients with glioblastoma multiforme
por: Villà, Salvador, et al.
Publicado: (2014) -
Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017) -
The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested
por: Ruiz-García, Raquel, et al.
Publicado: (2020) -
Clinical neuropathology practice guide 5-2012: Updated guideline for the diagnosis of anti-neuronal antibodies
por: Höftberger, Romana, et al.
Publicado: (2012) -
Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome
por: Sabater, Lidia, et al.
Publicado: (2016)